EIF3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.301000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.193000E-01
Normal-vs-Stage2
8.982800E-01
Normal-vs-Stage3
3.427200E-01
Normal-vs-Stage4
3.703400E-01
Stage1-vs-Stage2
9.411800E-01
Stage1-vs-Stage3
2.393200E-01
Stage1-vs-Stage4
2.454400E-01
Stage2-vs-Stage3
2.661800E-01
Stage2-vs-Stage4
1.362390E-01
Stage3-vs-Stage4
1.366570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.607800E-01
Normal-vs-AfricanAmerican
5.036600E-01
Normal-vs-Asian
7.354400E-01
Caucasian-vs-AfricanAmerican
2.173200E-01
Caucasian-vs-Asian
4.016000E-01
AfricanAmerican-vs-Asian
2.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.880400E-01
Normal-vs-Female
9.823600E-01
Male-vs-Female
6.320400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.558600E-01
Normal-vs-Age(41-60Yrs)
6.226200E-01
Normal-vs-Age(61-80Yrs)
9.009800E-01
Normal-vs-Age(81-100Yrs)
8.173800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.508200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.349600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.360600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.772350E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.947170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.175800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.949000E-01
Normal-vs-Daily Drinker
5.747600E-01
Normal-vs-Weekly Drinker
8.333800E-01
Normal-vs-Occasional Drinker
5.982600E-01
Normal-vs-Social Drinker
8.699400E-01
Non Drinker-vs-Daily Drinker
1.662240E-01
Non Drinker-vs-Weekly Drinker
6.454600E-01
Non Drinker-vs-Occasional Drinker
2.007000E-01
Non Drinker-vs-Social Drinker
7.467000E-01
Daily Drinker-vs-Weekly Drinker
5.056400E-01
Daily Drinker-vs-Occasional Drinker
4.509600E-02
Daily Drinker-vs-Social Drinker
1.861210E-01
Weekly Drinker-vs-Occasional Drinker
2.081000E-01
Weekly Drinker-vs-Social Drinker
5.388400E-01
Occasional Drinker-vs-Social Drinker
4.397000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.635770E-01
Normal-vs-Grade 2
4.055700E-02
Normal-vs-Grade 3
1.677780E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.056000E-01
Grade 1-vs-Grade 3
1.430760E-01
Grade 1-vs-Grade 4
1.635770E-01
Grade 2-vs-Grade 3
4.607800E-01
Grade 2-vs-Grade 4
4.055700E-02
Grade 3-vs-Grade 4
1.677780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.515200E-01
Normal-vs-NonDiabetic
8.921000E-01
Diabetic-vs-NonDiabetic
5.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.733400E-01
Normal-vs-NoPancreatitis
9.801400E-01
Pancreatitis-vs-NoPancreatitis
9.923800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.495600E-01
Normal-vs-N1
8.956000E-01
N0-vs-N1
8.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.624400E-01
Normal-vs-TP53-NonMutant
7.590400E-01
TP53-Mutant-vs-TP53-NonMutant
8.775800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
